LA County probes hospice and Botox fraud rings

LA County Fraud cases keep surfacing because the numbers refuse to shrink. State and federal prosecutors have traced hundreds of millions in Medicare and Medi-Cal payments to phantom hospice patients and nonexistent Botox injections, then watched that cash convert into luxury cars, overseas transfers, and real estate. The pattern is the same whether the scheme involves end-of-life billing or cosmetic injections: file the claim, skip the care, keep the difference.

Statewide Medi-Cal takedown

In April 2026 California Attorney General Rob Bonta charged twenty-one people with running fourteen sham hospice companies across Van Nuys, Tarzana, Glendale, Torrance, and Garden Grove. The ring used stolen identities from out-of-state residents to enroll fake patients, then submitted more than $267 million in claims for services never performed. Five defendants were arrested immediately, and agents seized $757,000 in cash plus handguns tied to the operation.

Straw owners bought the companies on paper while actual medical staff never appeared. Billing records listed hospice centers that did not exist and patient visits that never happened. The scheme relied on identity theft and fabricated paperwork rather than recruiting real patients, which made detection slower until data analytics flagged the volume.

Medi-Cal funds come from state and federal taxpayers, so every fraudulent dollar removed from legitimate care. The case established LA County addresses as the operational base even when the supposed patients lived elsewhere, confirming the county’s role as ground zero for this billing tactic.

Federal Medicare sweeps

April and October 2026 brought coordinated federal actions under the banner “Operation Never Say Die.” Prosecutors charged fifteen defendants in one October wave alone, alleging three separate hospice schemes that billed Medicare more than $138 million. Geoffrey Jimenez’s Transitions Hospice network, Dr. Richard Keech’s Torrance operation, and Armani Raffi’s four Sherman Oaks entities each showed live-discharge rates near 85 percent, far above the national average of 17 percent.

High live-discharge figures served as a statistical red flag because genuine hospice patients rarely recover enough to leave care. Agents also documented kickbacks paid to recruiters and physicians who certified terminal status without examinations. The clusters operated from single office buildings in Artesia and Glendale, mirroring the density pattern already noted in state audits.

First Assistant U.S. Attorney Bill Essayli stated that the volume of hospice fraud “happens entirely too much, particularly in Los Angeles County.” FBI Los Angeles officials described the region as a high-risk environment, citing both the concentration of providers and weak initial licensing controls that allowed rapid growth.

Clustering and oversight gaps

LA County currently lists roughly 1,800 hospice providers, about 30 to 40 percent of the national total despite representing a far smaller share of the terminally ill population. State auditors identified 742 of those providers with multiple fraud indicators, including multiple sites inside single buildings, low patient counts, and billing volumes that exceeded any plausible service capacity. One Van Nuys plaza alone housed 89 hospices.

CMS Administrator Dr. Mehmet Oz estimated that LA County accounts for $3.5 billion in annual hospice and home-health fraud. The state responded with a moratorium on new licenses that runs through January 2027, yet existing operators continue to file claims while investigations proceed. The density creates both competitive pressure to cut corners and practical difficulty for regulators trying to conduct site visits.

Overbilling in a single recent year reached an estimated $105 million according to state figures. That amount represents services claimed but never delivered, effectively transferring public funds into private accounts without any corresponding medical output.

Botox billing exposed

Parallel investigations into cosmetic-procedure fraud produced the May 2026 conviction of Glendale physician Violetta Mailyan. Prosecutors proved she billed Medicare more than $45 million for chronic-migraine Botox injections that were never administered or were purely cosmetic. Records showed claims filed on days her clinic was closed and during periods when she was traveling in Cabo or Maui.

Mailyan collected between $24 million and $33 million before agents moved in, six times the amount of the next-highest Medicare Botox provider. The case relied on the same data-analytics tools that flagged hospice outliers, demonstrating that outlier billing patterns cross service lines. Agents recovered a Tesla Cybertruck, a Tesla Model X, multiple properties, brokerage accounts totaling $7.3 million, and even an antique crossbow purchased with proceeds.

FBI Los Angeles Assistant Director Patrick Grandy called the scheme the largest Botox fraud prosecuted in the United States. The conviction on nine wire-fraud counts and three obstruction counts illustrated how a single practitioner could exploit Medicare’s reimbursement system without any actual patient interaction beyond initial record fabrication.

Money trails and asset seizures

Both hospice and Botox cases show rapid conversion of billed amounts into tangible assets. Straw owners in the $267 million Medi-Cal ring purchased luxury vehicles and real estate within months of incorporation. Mailyan’s portfolio included multiple high-end Teslas and out-of-state properties acquired while claims continued. Agents tracked wire transfers that moved funds offshore before accounts were frozen.

Seizure totals remain modest compared with billed amounts because operators quickly dissipate cash through layered accounts and third-party purchases. Still, the recovered assets demonstrate intent and provide restitution sources for affected public programs. Prosecutors have begun civil forfeiture proceedings against remaining holdings to offset some of the losses.

Financial analysis also revealed repeated use of the same bank accounts across different corporate entities, a pattern that allowed investigators to link seemingly separate operations. That linkage proved essential in expanding the October 2026 federal indictments beyond the initial three hospice networks.

Taxpayer cost calculation

Medicare and Medi-Cal operate on fixed budgets, so every dollar paid for nonexistent care reduces funds available for legitimate treatment. The combined $267 million state case and $138 million federal hospice actions alone represent more than $400 million removed from patient services in a single year. Adding the $45 million Botox scheme brings the documented total above $445 million for recent LA County prosecutions.

These figures capture only charged conduct. Auditors note that many additional providers display similar red flags but have not yet been fully investigated, suggesting the true exposure is higher. Each fraudulent claim also triggers follow-on administrative costs for claims processing, audits, and legal actions that further strain public resources.

Because both programs rely on federal matching funds, the loss extends beyond California taxpayers to every state that contributes to Medicare and Medi-Cal pools. The concentration of schemes inside LA County therefore creates a national fiscal impact disproportionate to the county’s population share.

Enforcement coordination

Recent actions required cooperation among the California Attorney General’s office, multiple U.S. Attorney districts, the FBI, and CMS data teams. Joint task forces used predictive analytics to rank providers by billing volume, discharge statistics, and address clustering before launching raids. That approach shortened the time between scheme launch and indictment compared with earlier cycles.

State licensing boards have begun cross-checking new applications against known straw-owner databases, though the current moratorium already limits fresh entries. Federal prosecutors continue to pursue parallel civil and criminal tracks, allowing asset freezes while criminal cases proceed through the courts.

Defense attorneys argue that some flagged providers simply serve high-turnover urban populations, yet the statistical outliers remain extreme enough that judges have granted most government motions for pretrial detention and asset restraint. The legal standard for probable cause has been met repeatedly in these filings.

Industry adjustments

Hospice operators inside LA County now face heightened scrutiny on every claim submission. Electronic health-record vendors have added flags for live-discharge rates above 30 percent, and Medicare administrative contractors have increased prepayment review thresholds for providers in the identified high-risk zip codes. These changes raise operating costs for legitimate agencies while slowing fraudulent cash flow.

Some networks have attempted to relocate billing addresses outside the moratorium zone, but federal investigators track practitioner National Provider Identifiers across state lines. The Botox conviction also prompted CMS to tighten documentation requirements for chronic-migraine injections, including mandatory prior authorization in certain regions.

Trade associations representing compliant hospice and pain-management providers have publicly supported the enforcement steps, noting that unchecked fraud damages reimbursement rates and public trust for the entire sector. Their statements emphasize that the majority of providers operate within guidelines and should not be conflated with the indicted networks.

Next investigative phase

Prosecutors have indicated that additional indictments tied to the same data sets are under seal. The focus is shifting from individual practitioners to management companies that supply billing software, patient recruiters, and straw owners across multiple schemes. Civil suits seeking treble damages under the False Claims Act are expected to follow criminal resolutions.

State legislators have introduced bills that would require hospice operators to maintain a minimum number of full-time clinical staff per admitted patient and to submit live-discharge data quarterly. If passed, the measures would raise the operational bar and make large-scale phantom billing more difficult to conceal.

Federal sentencing guidelines for health-care fraud now include enhancements for schemes exceeding $10 million and for abuse of vulnerable populations, both of which apply to the hospice cases. Early plea discussions suggest some defendants may cooperate in exchange for reduced exposure, potentially revealing additional networks still operating inside the county.

Forward implications

LA County Fraud enforcement has moved from reactive casework to proactive data modeling, yet the underlying incentive structure remains unchanged: high reimbursement rates, low verification, and rapid asset conversion. Until licensing density and documentation standards align with actual patient need, new schemes will continue to test the same vulnerabilities that produced the current wave of indictments.